L-Erythrose

CAS : 533-49-3

Ref. 3D-ME00260

Informations sur le produit

• Nom: L-Erythrose
• Synonymes: (2S,3S)-2,3,4-Trihydroxybutanal, Erythrose, L-, Butanal, 2,3,4-trihydroxy-, [S-(R*,R*)]-, Butanal, 2,3,4-trihydroxy-, (2S,3S)-

Description

L-Erythrose is a monosaccharide that contains an hydroxyl group on the second carbon atom. It can be synthesized by a synthetic scheme involving glycolaldehyde and hydroxylamine. L-Erythrose has been shown to inhibit the enzyme phosphoglycerate kinase, which converts 2-phosphoglycerate into phosphoenolpyruvate. L-Erythrose has also been shown to inhibit dehydroascorbic acid reductase, which converts dehydroascorbic acid into ascorbic acid, and galactitol reductase, which converts galactitol into D-tagatose. The mutant strain of Escherichia coli K12 that was engineered to produce L-erythrose showed a decreased susceptibility to phage infection and an increased resistance to oxidative stress. In addition, the polyol pathway in E. coli was induced by L-erythrose treatment.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 120.1 g/mol
• Formule: C₄H₈O₄
• Degré de pureté: Min. 95%
• Couleur/Forme: Slightly Yellow Powder